XNAS: AVTX
Avalo Therapeutics Inc Live Stock Price Today, Share Analysis and Chart
about
Avalo Therapeutics Inc is a clinical stage biotechnology company fully dedicated to developing IL-1B-based treatments for immune-mediated inflammatory diseases. The company's asset is Abdakibart (AVTX-009) an anti-IL-1B monoclonal antibody ("mAb"), t...
Read More
19.21
-0.74
(-3.71%)
852.8K
XNAS Volume
XNAS 10 Jul, 2026 5:30 PM (EDT)
Not Eligible
Expensive Valuation
Technically Moderately Bullish
Avalo Therapeutics Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..